SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories approves dividend

16 May 2025 Evaluate
Neuland Laboratories has informed that the Board of Directors at their meeting held on even date, have considered and approved- the Audited Financial Results (Standalone & Consolidated) as per Indian Accounting Standards (IND AS) for the year ended March 31, 2025 along with Statement of Assets and Liabilities as on March 31, 2025 (enclosed). The Statutory Auditors of the Company, MSKA &. Associates, Chartered Accountants, have issued audit reports with unmodified opinion on the financial statements; Recommended payment of final dividend of Rs 12 (120 %) per equity share on a face value of Rs.10 each, for the financial year 2024-25. The dividend will be paid on or after five days from the date of declaration of the final dividend by the shareholders at the 41st Annual General Meeting (AGM); Re-appointment of Davuluri Saharsh Rao (DIN: 02753145), as Whole Time Director, designated as Vice Chairman & Managing Director, for a further period of 5 (five) years, with effective from June 1, 2025, basis the recommendation of the Nomination and Remuneration Committee, subject to the approval of the shareholders of the Company in the ensuing AGM.

The above information is a part of company’s filings submitted to BSE.

Neuland Laboratories Share Price

14408.95 -539.25 (-3.61%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×